Abstract
FDG-PET is an established supportive biomarker in dementia with Lewy bodies (DLB), but its diagnostic accuracy is unknown in prodromal stages (MCI-LB) when the typical metabolic pattern may be difficultly recognized at the individual level. Semiquantitative analysis of scans can enhance accuracy especially in less skilled readers, but its added role with respect to visual assessment at this DLB stage is still unknown.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
